Title | Type | SJR | H index | Total Docs. (2014) | Total Docs. (3years) | Total Refs. (2014) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2014) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
180 | Advances in Pharmacological Sciences | journal | 0.818 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
179 | BMC Chemical Biology | journal | 0.328 Q4 | 21 | 0 | 7 | 0 | 9 | 7 | 1.80 | 0.00 | |
178 | Cellular Oncology | journal | 0.853 Q3 | 44 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
177 | Cellular Therapy and Transplantation | journal | 0.102 Q4 | 8 | 0 | 10 | 0 | 1 | 10 | 0.00 | 0.00 | |
176 | Current Biomarkers | journal | 0.134 Q4 | 3 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
175 | Current Chemical Genomics | journal | 1.198 Q2 | 16 | 0 | 14 | 0 | 34 | 13 | 0.00 | 0.00 | |
174 | Drug Discovery Today: Disease Mechanisms | journal | 0.623 Q3 | 28 | 0 | 42 | 0 | 39 | 37 | 0.85 | 0.00 | |
173 | Drug Discovery Today: Therapeutic Strategies | journal | 0.340 Q4 | 31 | 0 | 72 | 0 | 72 | 65 | 0.61 | 0.00 | |
172 | Expert Opinion on Medical Diagnostics | journal | 0.525 Q3 | 28 | 0 | 160 | 0 | 237 | 156 | 1.63 | 0.00 | |
171 | Gene Therapy and Regulation | journal | 0.251 Q4 | 7 | 0 | 11 | 0 | 13 | 10 | 1.60 | 0.00 | |
170 | Genetic Vaccines and Therapy | journal | 0.477 Q3 | 30 | 0 | 24 | 0 | 35 | 24 | 1.44 | 0.00 | |
169 | IEEE International Conference on Nano/Molecular Medicine and Engineering, NANOMED | conference and proceedings | 0.134 | 5 | 0 | 58 | 0 | 8 | 54 | 0.14 | 0.00 | |
168 | MedChemComm | journal | 0.942 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
167 | Molecular Interventions | journal | 1.796 Q1 | 78 | 0 | 20 | 0 | 86 | 12 | 0.00 | 0.00 | |
166 | Open Bioactive Compounds Journal | journal | 0.106 Q4 | 6 | 0 | 4 | 0 | 1 | 4 | 0.25 | 0.00 | |
165 | Open Pharmacology Journal | journal | 0.104 Q4 | 6 | 0 | 10 | 0 | 1 | 9 | 0.11 | 0.00 | |
164 | Sp2 | trade journal | 0.100 Q4 | 2 | 37 | 123 | 16 | 0 | 103 | 0.00 | 0.43 | |
163 | Journal of Experimental Pharmacology | journal | 0.994 Q2 | 23 | 1 | 3 | 23 | 9 | 3 | 3.00 | 23.00 | |
162 | Current Chemical Genomics and Translational Medicine | journal | 9 | 5 | 0 | 120 | 0 | 0 | 0.00 | 24.00 | ||
161 | Recent Patents on Biomarkers | journal | 3 | 1 | 13 | 126 | 3 | 12 | 0.23 | 126.00 | ||
160 | Methods in molecular medicine | book series | 59 | 4 | 0 | 228 | 0 | 0 | 0.00 | 57.00 | ||
159 | Open Medicinal Chemistry Journal | journal | 0.743 Q3 | 23 | 4 | 24 | 233 | 78 | 23 | 1.45 | 58.25 | |
158 | Molecular Therapy - Oncolytics | journal | 42 | 6 | 0 | 290 | 0 | 0 | 0.00 | 48.33 | ||
157 | Pteridines | journal | 0.174 Q4 | 19 | 9 | 53 | 297 | 20 | 52 | 0.24 | 33.00 | |
156 | VacciMonitor | journal | 0.120 Q4 | 5 | 19 | 46 | 341 | 8 | 44 | 0.17 | 17.95 | |
155 | Drugs in Context | journal | 0.161 Q4 | 36 | 7 | 16 | 361 | 15 | 14 | 0.94 | 51.57 | |
154 | Analytical Cellular Pathology | journal | 0.575 Q3 | 35 | 11 | 82 | 414 | 122 | 76 | 1.33 | 37.64 | |
153 | Biomarker Insights | journal | 0.937 Q3 | 40 | 13 | 49 | 424 | 133 | 49 | 2.72 | 32.62 | |
152 | MCB Molecular and Cellular Biomechanics | journal | 0.389 Q4 | 31 | 11 | 50 | 479 | 58 | 50 | 1.22 | 43.55 | |
151 | Progress in Medicinal Chemistry | journal | 1.293 Q2 | 38 | 5 | 17 | 534 | 61 | 1 | 3.27 | 106.80 | |
150 | Biomolecular Detection and Quantification | journal | 29 | 10 | 0 | 609 | 0 | 0 | 0.00 | 60.90 | ||
149 | Current Enzyme Inhibition | journal | 0.212 Q4 | 19 | 16 | 55 | 683 | 27 | 49 | 0.43 | 42.69 | |
148 | Human Genomics | journal | 1.446 Q2 | 68 | 21 | 86 | 778 | 279 | 79 | 2.20 | 37.05 | |
147 | Nucleus (India) | journal | 0.181 Q4 | 17 | 27 | 56 | 824 | 26 | 55 | 0.48 | 30.52 | |
146 | Current Pharmacogenomics and Personalized Medicine | journal | 0.220 Q4 | 20 | 16 | 109 | 867 | 84 | 86 | 0.62 | 54.19 | |
145 | Profiles of Drug Substances, Excipients and Related Methodology | journal | 0.172 Q4 | 29 | 10 | 36 | 877 | 28 | 0 | 0.72 | 87.70 | |
144 | European Pharmaceutical Review | trade journal | 0.112 Q4 | 9 | 54 | 143 | 883 | 16 | 143 | 0.07 | 16.35 | |
143 | Gene Therapy and Molecular Biology | journal | 0.118 Q4 | 18 | 25 | 30 | 900 | 6 | 30 | 0.20 | 36.00 | |
142 | Biomarker Research | journal | 48 | 26 | 31 | 999 | 97 | 30 | 3.13 | 38.42 | ||
141 | Turkish Journal of Pharmaceutical Sciences | journal | 0.188 Q4 | 22 | 39 | 100 | 1033 | 48 | 100 | 0.48 | 26.49 | |
140 | Central Nervous System Agents in Medicinal Chemistry | journal | 0.895 Q3 | 39 | 15 | 88 | 1044 | 212 | 79 | 2.35 | 69.60 | |
139 | Genomics Data | journal | 0.238 Q4 | 27 | 108 | 3 | 1062 | 1 | 2 | 0.33 | 9.83 | |
138 | Probiotics and Antimicrobial Proteins | journal | 0.386 Q4 | 52 | 23 | 87 | 1110 | 107 | 87 | 1.24 | 48.26 | |
137 | Journal of Gene Medicine | journal | 0.808 Q3 | 100 | 26 | 172 | 1224 | 443 | 166 | 2.84 | 47.08 | |
136 | BBA Clinical | journal | 35 | 24 | 0 | 1235 | 0 | 0 | 0.00 | 51.46 | ||
135 | Drug Discovery Today: Disease Models | journal | 0.373 Q4 | 33 | 26 | 91 | 1240 | 64 | 80 | 0.42 | 47.69 | |
134 | AIDS Research and Therapy | journal | 0.924 Q3 | 49 | 39 | 113 | 1262 | 241 | 112 | 1.84 | 32.36 | |
133 | Current Pharmaceutical Analysis | journal | 0.243 Q4 | 27 | 36 | 129 | 1263 | 102 | 127 | 0.82 | 35.08 | |
132 | Journal of Stem Cells | journal | 0.285 Q4 | 21 | 21 | 67 | 1296 | 57 | 66 | 0.86 | 61.71 | |
131 | Forum on Immunopathological Diseases and Therapeutics | journal | 0.175 Q4 | 14 | 23 | 79 | 1342 | 33 | 71 | 0.48 | 58.35 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®